Biogen (Germany) Today
| IDP Stock | EUR 184.65 2.75 1.51% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Biogen is trading at 184.65 as of the 24th of April 2024. This is a 1.51 percent up since the beginning of the trading day. The stock's lowest day price was 180.95. Biogen has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Biogen Inc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 4th of June 2022 and ending today, the 24th of April 2024. Click here to learn more.
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases worldwide. The company was founded in 1978 and is headquartered in Cambridge, Massachusetts. BIOGEN INC operates under Drug ManufacturersGeneral classification in Germany and is traded on Frankfurt Stock Exchange. The company has 144.49 M outstanding shares. More on Biogen Inc
Moving together with Biogen Stock
| 0.81 | AMG | Amgen Inc | PairCorr |
Moving against Biogen Stock
| 0.83 | AMZ | Amazon Inc Earnings Call Tomorrow | PairCorr |
| 0.82 | AMZ | Amazon Inc Earnings Call This Week | PairCorr |
| 0.77 | HHP2 | Hon Hai Precision | PairCorr |
| 0.77 | VOW | Volkswagen AG Earnings Call This Week | PairCorr |
| 0.74 | VOWA | VOLKSWAGEN ADR 110ON | PairCorr |
| 0.57 | WMT | Walmart Split | PairCorr |
| 0.57 | WMT | Walmart Split | PairCorr |
Biogen Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Biogen's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Biogen or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Drug Manufacturers—General, Healthcare (View all Sectors) |
Biogen Inc (IDP) is traded on Frankfurt Exchange in Germany and employs 8,725 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 36.91 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Biogen's market, we take the total number of its shares issued and multiply it by Biogen's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Biogen Inc classifies itself under Healthcare sector and is part of Drug Manufacturers—General industry. The entity has 144.49 M outstanding shares.
Biogen Inc has accumulated about 2.54 B in cash with 1.38 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 16.85.
Check Biogen Probability Of Bankruptcy
Ownership AllocationBiogen holds a total of 144.49 Million outstanding shares. The majority of Biogen Inc outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Biogen Inc to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Biogen. Please pay attention to any change in the institutional holdings of Biogen Inc as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Biogen Ownership Details
Biogen Stock Price Odds Analysis
In reference to a normal probability distribution, the odds of Biogen jumping above the current price in 90 days from now is about 91.39%. The Biogen Inc probability density function shows the probability of Biogen stock to fall within a particular range of prices over 90 days. Assuming the 90 days horizon Biogen has a beta of 0.6762. This usually indicates as returns on the market go up, Biogen average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Biogen Inc will be expected to be much smaller as well. Additionally, biogen Inc has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Biogen to move above the current price in 90 days from now is about 91.39 (This Biogen Inc probability density function shows the probability of Biogen Stock to fall within a particular range of prices over 90 days) .
Biogen Inc Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Biogen market risk premium is the additional return an investor will receive from holding Biogen long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Biogen. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Biogen's alpha and beta are two of the key measurements used to evaluate Biogen's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.11 | |||
| Standard Deviation | 1.42 | |||
| Variance | 2.01 | |||
| Risk Adjusted Performance | (0.13) |
Biogen Stock Against Markets
Picking the right benchmark for Biogen stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Biogen stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Biogen is critical whether you are bullish or bearish towards Biogen Inc at a given time. Please also check how Biogen's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Biogen without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Insider Screener Now
Insider ScreenerFind insiders across different sectors to evaluate their impact on performance |
| All Next | Launch Module |
Biogen Corporate Management
Elected by the shareholders, the Biogen's board of directors comprises two types of representatives: Biogen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Biogen. The board's role is to monitor Biogen's management team and ensure that shareholders' interests are well served. Biogen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Biogen's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Christopher Viehbacher | CEO Pres | Profile | |
| Robin Kramer | VP Officer | Profile | |
| Sanjay Jariwala | VP Medical | Profile | |
| Ginger Gregory | Ex Officer | Profile | |
| Anabella Villalobos | Head Sciences | Profile | |
| Susan Esq | Chief VP | Profile | |
| Michael CPA | Ex CFO | Profile |
How to buy Biogen Stock?
Before investing in Biogen, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Biogen. To buy Biogen stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Biogen. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Biogen stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Biogen Inc stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Biogen Inc stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Biogen Inc, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Biogen Stock please use our How to Invest in Biogen guide.
Already Invested in Biogen Inc?
The danger of trading Biogen Inc is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Biogen is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Biogen. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Biogen Inc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Biogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biogen Inc Stock: Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Biogen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Complementary Tools for Biogen Stock analysis
When running Biogen's price analysis, check to measure Biogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biogen is operating at the current time. Most of Biogen's value examination focuses on studying past and present price action to predict the probability of Biogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biogen's price. Additionally, you may evaluate how the addition of Biogen to your portfolios can decrease your overall portfolio volatility.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |